Apoptosis in skin wound healing

Wounds

Volumn 15, Issue 6, 2003, Pages 182-194

  Huang, Ngan Fong ^a,b,e   Zac Varghese, Sagen ^c   Luke, Sunny ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Ortec International Inc   (United States)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d ADELPHI UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; DNA; FAS ANTIGEN; LIPOCORTIN 5; PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR;

APOPTOSIS; CAENORHABDITIS ELEGANS; CELL MATURATION; CYTOMETRY; DNA CONTENT; DNA DAMAGE; ELECTRON MICROSCOPY; EVOLUTION; FLOW CYTOMETRY; GRANULATION TISSUE; HYPERTROPHIC SCAR; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INFLAMMATORY CELL; KELOID; LASER MICROSCOPY; MICROSCOPY; MITOCHONDRION; MOLECULAR BIOLOGY; MOLECULAR MECHANICS; NICK END LABELING; NONHUMAN; REGULATORY MECHANISM; REVIEW; SCAR; SKIN; SKIN INJURY; STAINING; WOUND HEALING;

EID: 0038449281     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (119)

1. Deveraux QL, Roy N, Stennicke HR, et al. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. Embo J 1998;17:2215-23.
2. Bortner CD, Cidlowski JA. Cellular mechanisms for the repression of apoptosis. Annu Rev Pharmacol Toxicol 2002;42:259-81.
3. Kerr JF, Wyllie AH, Currie AR. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26:239-57.
4. Fadeel B, Orrenius S, Zhivotovsky B. Apoptosis in human disease: A new skin for the old ceremony? Biochem Biophys Res Commun 1999;266:699-717.
5. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995;267:1456-62.
6. Wang TH, Wang HS. p53, apoptosis, and human cancers. J Formos Med Assoc 1996;95:509-22.
7. Desmouliere A, Redard M, Darby I, et al. Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. Am J Pathol 1995;146:56-66.
8. Hale AJ, Smith CA, Sutherland LC, et al. Apoptosis: Molecular regulation of cell death. Eur J Biochem 1996;236:1-26.
9. Au JL, Panchal N, Li D, et al. Apoptosis: A new pharmacodynamic endpoint. Pharm Res 1997;14:1659-71.
10. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-30.
11. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today 1997;18:44-51.
12. Blatt NB, Glick GD. Signaling pathways and effector mechanisms pre-programmed cell death. Bioorg Med Chem 2001;9:1371-84.
13. Hampton MB, Vanags DM, Porn-Ares MI, et al. Involvement of extracellular calcium in phosphatidylserine exposure during apoptosis. FEBS Lett 1996;399:277-82.
14. Bratton DL, Fadok VA, Richter DA, et al. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem 1997;272:26159-65.
15. Wyllie AH. Apoptosis: Cell death in tissue regulation. J Pathol 1987;153:313-6.
16. Walker NI, Harmon BV, Gobe GC, et al. Patterns of cell death. Methods Achiev Exp Pathol 1988;13:18-54.
17. Schwartzman RA, Cidlowski JA. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 1993;14:133-51.
18. Darzynkiewicz Z, Bruno S, Del Bino G, et al. Features of apoptotic cells measured by flow cytometry. Cytometry 1992;13:795-808.
19. Wyllie AH, Kerr JF, Currie AR. Cell death: The significance of apoptosis. Int Rev Cytol 1980;68:251-306.
20. Evans R, Cidlowski JA. Apoptosis: Cellular signaling and molecular mechanisms. In: Oliver C (ed). Cell Biology of Trauma. Boston, MA: CRC Press, 1995;25-47.
21. Ellis RE, Jacobson DM, Horvitz HR. Genes required for the engulfment of cell corpses during programmed cell death in Caenorhabditis elegans. Genetics 1991;129:79-94.
22. Roth KA. Caspases, apoptosis, and Alzheimer's disease: Causation, correlation, and confusion. J Neuropathol Exp Neurol 2001;60:829-38.
23. Zou H, Henzel WJ, Liu X, et al. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997;90:405-13.
24. Ashkenazi A, Dixit VM. Death receptors: Signaling and modulation. Science 1998;281:1305-8.
25. Teraki Y, Shiohara T. Apoptosis and the skin. Eur J Dermatol 1999;9:413-425;quiz 426.
26. al-Rubeai M, Singh RP. Apoptosis in cell culture. Curr Opin Biotechnol 1998;9:152-6.
27. Yang E, Korsmeyer SJ. Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 1996;88:386-401.
28. Bellamy CO, Malcomson RD, Harrison DJ, et al. Cell death in health and disease: The biology and regulation of apoptosis. Semin Cancer Biol 1995;6:3-16.
29. Schwartzman RA, Cidlowski JA. Glucocorticold-induced apoptosis of lymphoid cells. Int Arch Allergy Immunol 1994;105:347-54.
30. Salvesen GS, Dixit VM. Caspases: Intracellular signaling by proteolysis. Cell 1997;91:443-6.
31. Marshman E, Ottewell PD, Potten CS, et al. Caspase activation during spontaneous and radiation-induced apoptosis in the murine intestine. J Pathol 2001;195:285-92.
32. Clerk A, Cole SM, Cullingford TE, et al. Regulation of cardiac myocyte cell death. Pharmacol Ther 2003;97:223-61.
33. Hay BA. Understanding IAP function and regulation: A view from Drosophila. Cell Death Differ 2000;7:1045-56.
34. Deveraux QL, Reed JC. IAP family proteins: Suppressors of apoptosis. Genes Dev 1999;13:239-52.
35. Miller LK. An exegesis of IAPs: Salvation and surprises from BIR motifs. Trends Cell Biol 1999;9:323-8.
36. Salvesen GS, Duckett CS. IAP proteins: Blocking the road to death's door. Nat Rev Mol Cell Biol 2002;3:401-10.
37. Clem RJ, Miller LK. Control of programmed cell death by the baculovirus genes p35 and iap. Mol Cell Biol 1994;14:5212-22.
38. Duckett CS, Nava VE, Gedrich RW, et al. A conserved family of cellular genes related to the baculovirus iap gene and encoding apoptosis inhibitors. Embo J 1996;15:2685-94.
39. Liston P, Roy N, Tamai K, et al. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996;379:349-53.
40. Roy N, Mahadevan MS, McLean M, et al. The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 1995;80:167-78.
41. Deveraux QL, Takahashi R, Salvesen GS, et al. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997;388:300-4.
42. Tsujimoto Y, Cossman J, Jaffe E, et al. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985;228:1440-3.
43. Deveraux QL, Schendel SL, Reed JC. Anti-apoptotic proteins. The bcl-2 and inhibitor of apoptosis protein families. Cardiol Clin 2001;19:57-74.
44. Cheng EH, Levine B, Boise LH, et al. Bax-independent inhibition of apoptosis by Bcl-XL. Nature 1996;379:554-6.
45. Chao DT, Korsmeyer SJ. BCL-XL-regulated apoptosis in T cell development. Int Immunol 1997;9:1375-84.
46. Cameron R, Feuer G. Molecular cellular and tissue reactions of apoptosis and their modulation by drugs. In: Feuer G (ed). Handbook of Experimental Pharmacology. New York, NY: Springer, 2000;38-57.
47. Adams JM. Understanding the Y2K problem in health care: Party's over, we're out of time. Nurs Econ 1998;16:138-9, 143.
48. Kelekar A, Thompson CB. Bcl-2-family proteins: The role of the BH3 domain in apoptosis. Trends Cell Biol 1998;8:324-30.
49. Reed JC. Bcl-2 family proteins. Oncogene 1998;17:3225-36.
50. Gross A, McDonnell JM, Korsmeyer SJ. BCL-2 family members and the mitochondria in apoptosis. Genes Dev 1999;13:1899-911.
51. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
52. Lane DP. Cancer. p53, guardian of the genome. Nature 1992;358:15-6.
53. Kastan MB, Onyekwere O, Sidransky D, et al. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991;51:6304-11.
54. Picksley SM, Lane DP. p53 and Rb: Their cellular roles. Curr Opin Cell Biol 1994;6:853-8.
55. McCarthy N, Mercer J, Bennett M. Apoptotic proteins, p53 and c-myc related pathways. Cardiol Clin 2001;19:75-89, viii.
56. Wu X, Bayle JH, Olson D, et al. The p53-mdm-2 autoregulatory feedback loop. Genes Dev 1993;7:1126-32.
57. Rouault JP, Falette N, Guehenneux F, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 1996;14:482-6.
58. el-Deiry WS, Harper JW, O'Connor PM, et al. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res 1994;54:1169-74.
59. Chang NS. A potential role of p53 and WOX1 in mitochondrial apoptosis (review). Int J Mol Med 2002;9:19-24.
60. Sheikh MS, Hollander MC, Fornance AJ, Jr. Role of Gadd45 in apoptosis. Biochem Pharmacol 2000;59:43-5.
61. Fiscella M, Zhang H, Fan S, et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 1997;94:6048-53.
62. Hermeking H, Lengauer C, Polyak K, et al. 14-3-3 sigma is a p53-regulated inhibitor of G2/M progression. Mol Cell 1997;1:3-11.
63. Burma S, Kurimasa A, Xie G, et al. DNA-dependent protein kinase-independent activation of p53 in response to DNA damage. J Biol Chem 1999;274:17139-43.
64. Jimenez GS, Bryntesson F, Torres-Arzayus MI, et al. DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage. Nature 1999;400:81-3.
65. Khosravi R, Maya R, Gottlieb T, et al. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 1999;96:14973-77.
66. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991;66:233-43.
67. Oehm A, Behrmann I, Falk W, et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor super-family. Sequence identity with the Fas antigen. J Biol Chem 1992;267:10709-15.
68. Suda T, Tanaka M, Miwa K, et al. Apoptosis of mouse naive T cells induced by recombinant soluble Fas ligand and activation-induced resistance to Fas ligand. J Immunol 1996;157:3918-24.
69. Kischkel FC, Hellbardt S, Behrmann I, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Embo J 1995;14:5579-88.
70. Duan H, Dixit VM. RAIDD is a new 'death' adaptor molecule. Nature 1997;385:86-9
71. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241:139-76.
72. Pastorino JG, Chen ST, Tafani M, et al. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 1998;273:7770-5.
73. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995;80:293-9.
74. Owen-Schaub LB, Zhang W, Cusack JC, et al. Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol Cell Biol 1995;15:3032-40.
75. Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994;370:220-3.
76. Harmon B, Winterford C, O'Brien B, et al. Morphological criteria for identifying apoptosis. In: Cells J (ed). Cell Biology: A Laboratory Handbook. New York, NY: Academic Press, 1998;327-40.
77. Kerr JF, Gobe GC, Winterford CM, et al. Anatomical methods in cell death. Methods Cell Biol 1995;46:1-27.
78. Sanders EJ. Methods for detecting apoptotic cells in tissues. Histol Histopathol 1997;12:1169-77.
79. Perry SW, Epstein LG, Gelbard HA. In-situ trypan blue staining of monolayer cell cultures for permanent fixation and mounting. Biotechniques 1997;22:1020-4.
80. Petit PX, Lecoeur H, Zorn E, et al. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol 1995;130:157-67.
81. van Heerde WL, Robert-Offerman S, Dumont E, et al. Markers of apoptosis in cardiovascular tissues: Focus on Annexin V. Cardiovasc Res 2000;45:549-59.
82. Vermes I, Haanen C, Steffens-Nakken H, et al. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods 1995;184:39-51.
83. Smyth M. Flow cytometry in the study of apoptosis. In: Boustany R (ed). Apoptosis in Neurobiology. New York, NY: CRC Press, 1999;183-204.
84. Cunningham R. Overview of flow cytometry and fluorescent probes for cytometry. In: Javois H (ed). Immumocytochemical Methods and Protocols. Totowa, NI: Humana Press, 1999;249-56.
85. Puranam KL, Boustany RM. Assessment of cell viability and histochemical methods in apoptosis. In: Hannun YA, Boustany RM (eds). Apoptosis in Neurobiology. New York, NY: CRC Press, 1999;129-52.
86. Schmitz GG, Walter T, Seibl R, et al. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem 1991;192:222-31.
87. Darzynkiewicz Z, Bedne RE, Burfeind P, et al. Analysis of apoptosis by flow and laser scanning cytometry. In: Chun J (ed). Apoptosis Detection and Assay Methods. Westborough, MA: BioTechniques Books, 1998;75-91.
88. Darzynkiewicz Z, Bedner E, Smolewski P. Analysis of apoptosis by laser-scanning cytometry. In: Davis M (ed). Apoptosis methods in Pharmacology and Toxicology: Approaches to Measurement and Quantification. Totowa, NJ: Humana Press, 2002; 37-58.
89. Huppertz B, Frank HG, Kaufmann P. The apoptosis cascade: Morphological and immunohistochemical methods for its visualization. Anat Embryol (Berl) 1999;200:1-18.
90. Soini Y, Kinnula V, Kaarteenaho-Wiik R, et al. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma. Clin Cancer Res 1999;5:3508-15.
91. Soini Y, Paakko P. Apoptosis and expression of caspases 3, 6 and 8 in malignant non-Hodgkin's lymphomas. Apmis 1999;107:1043-50.
92. Greenhalgh DG. The role of apoptosis in wound healing. Int J Biochem Cell Biol 1998;30:1019-30.
93. Staiano-Coico L, Higgins PJ, Schwartz SB, et al. Wound fluids: A reflection of the state of healing. Ost/Wound Manag 2000;46:85S-93S; quiz 94S-95S.
94. McCartney-Francis N, Wahl S. TGF-beta and macrophages in the rise and fall of inflammation in TGF-beta and related cytokines in inflammation. In: Wahl S (ed). TGF-beta and Related Cytokines in Inflammation. Basel, Switzerland: Birkhauser, 2001;65-90.
95. Stocum D. Wound, Repair, Regeneration, and Artificial Tissues. Austin, TX: RD Landes Company, 1995.
96. Newman SL, Henson JE, Henson PM. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J Exp Med 1982;156:430-42.
97. Assoian RK, Fleurdelys BE, Stevenson HC, et al. Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987;84:6020-4.
98. Madtes DK, Raines EW, Sakariassen KS, et al. Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell 1988;53:285-93.
99. Shimokado K, Raines EW, Madtes DK, et al. A significant part of macrophage-derived growth factor consists of at least two forms of PDGF. Cell 1985;43:277-86.
100. Baird A, Mormede P, Bohlen P. Immunoreactive fibroblast growth factor in cells of peritoneal exudate suggests its identity with macrophage-derived growth factor. Biochem Biophys Res Commun 1985;126:358-64.
101. Huttunen M, Aalto ML, Harvima RJ, et al. Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds. Exp Dermatol 2000;9:258-65.
102. Kondo S. The roles of keratinocyte-derived cytokines in the epidermis and their possible responses to UVA-irradiation. J Investig Dermatol Symp Proc 1999;4:177-83.
103. Pilcher BK, Dumin JA, Sudbeck BD, et al. The activity of collagenase-1 is required for keratinocyte migration on a type I collagen matrix. J Cell Biol 1997;137:1445-57.
104. Clark RA, Lanigan JM, DellaPelle P, et al. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. J Invest Dermatol 1982;79:264-9.
105. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med 1999;341:738-46.
106. Hunt T. Wound Healing and Wound Infection: Theory and Surgical Practice. New York, NY: Appleton-Century-Crofts, 1980.
107. Bussolino F, Albini A, Camussi G, et al. Role of soluble mediators in angiogenesis. Eur J Cancer 1996;32A:2401-12.
108. Heldin CH, Westermark B. Mechanism of action and in-vivo role of platelet-derived growth factor. Physiol Rev 1999;79:1283-316.
109. Liekens S, De Clercq E, Neyts J. Angiogenesis: Regulators and clinical applications. Biochem Pharmacol 2001;61:253-70.
110. Clark RA, Quinn JH, Winn HJ, et al. Fibronectin is produced by blood vessels in response to injury. J Exp Med 1982;156:646-51.
111. Mignatti P, Rifkin D, Welgus H, et al. Proteinases and tissue remodeling. In: Clark RA (ed). The Molecular and Cellular Biology of Wound Repair. New York, NY: Plenum Press, 1996;427-74.
112. Brown DL, Kao WW, Greenhalgh DG. Apoptosis down-regulates inflammation under the advancing epithelial wound edge: Delayed patterns in diabetes and improvement with topical growth factors. Surgery 1997;121:372-80.
113. Kane CD, Greenhalgh DG. Expression and localization of p53 and bcl-2 in healing wounds in diabetic and nondiabetic mice. Wound Rep Reg 2000;8:45-58.
114. Rossio-Pasquier P, Casanova D, Jomard A, et al. Wound healing of human skin transplanted onto the nude mouse after a superficial excisional injury: Human dermal reconstruction is achieved in several steps by two different fibroblast subpopulations. Arch Dermatol Res 1999;291:591-9.
115. Nagata M, Takenaka H, Shibagaki R, et al. Apoptosis and p53 protein expression increase in the process of burn wound healing in guinea-pig skin. Br J Dermatol 1999;140:829-38.
116. Wassermann RJ, Polo M, Smith P, et al. Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. J Surg Res 1998;75:74-80.
117. Teofoli P, Barduagni S, Ribuffo M, et al. Expression of Bcl-2, p53, c-jun and c-fos protooncogenes in keloids and hypertrophic scars. J Dermatol Sci 1999;22:31-7.
118. Tredget EE, Nedelec B, Scott PG, et al. Hypertrophic scars, keloids, and contractures. The cellular and molecular basis for therapy. Surg Clin North Am 1997;77:701-30.
119. Sayah DN, Soo C, Shaw WW, et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res 1999;87:209-16.